Medical Simulation Market : Geographical Snapshot

The medical simulation market is expected to reach USD 2,575.4 Million by 2022 from USD 1.120.8 Million in 2016, at a CAGR of 14.9% during the forecast period (2017–2022). Medical simulation is the advanced methodology for training healthcare professionals through the use of advanced educational technology. Simulation-based medical education is defined as any educational activity that utilizes simulation aides to replicate clinical scenarios. 

Geographically, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2016, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. The ease of accessibility to technologies, well-established distribution channels, and rising number of healthcare professionals demanding hands on patient training are the major factors driving the growth of the market in North America. 

Market Key Drivers:
1 Benefits of Simulation Over Traditional Learning
2 Increasing Demand for Minimally Invasive Treatments
3 Increasing Focus on Patient Safety
 
Key Market Opportunities:
1 Shortage of Healthcare Personnel
2 Technological Advancements
3 Growing Awareness on Simulation Education in Emerging Countries

Know More: https://www.marketsandmarkets.com/Market-Reports/healthcare-medical-simulation-market-1156.html

The prominent players in the global Market are CAE (Canada), Laerdal Medical (Norway), 3D Systems (US), Simulab Corporation (US), Simulaids (US), Limbs & Things (US), Kyoto Kagaku (Japan), Mentice (Sweden), Medaphor (UK), and Gaumard Scientific Company (US).

Comments